Evidence map›Paper›PMID 28100499›Full record

ArticleAmerican journal of physiology. Renal physiology2017

Gremlin1 plays a key role in kidney development and renal fibrosis.

Rachel H Church, Imran Ali, Mitchel Tate, Deborah Lavin, Arjun Krishnakumar, Helena M Kok, Jose R Hombrebueno, Philip D Dunne, Victoria Bingham, Roel Goldschmeding and 2 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Depletion of marrow adipo-CAR cells in mice enhances bone formation by activating bone morphogenetic protein receptor (BMPR) in pre-osteoblasts.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Article
  7. Article
  8. Efficient and selective kidney targeting by chemically modified carbohydrate conjugates.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Agonists of prostaglandin EProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Rachel H ChurchCentre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Imran AliCentre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Mitchel TateCentre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Deborah LavinCentre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Arjun KrishnakumarCentre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Helena M KokUtrecht Medical Centre, Utrecht, The Netherlands.
Jose R HombrebuenoCentre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Philip D DunneCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland.
Victoria BinghamCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland.
Roel GoldschmedingUtrecht Medical Centre, Utrecht, The Netherlands.
Finian MartinConway Institute, University College Dublin, Dublin, Ireland; and.
Derek P BrazilCentre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom; d.brazil@qub.ac.uk.
Queen's University Belfast · GBUniversity Medical Center Utrecht · NLUniversity College Dublin · IE

Funding

Biotechnology and Biological Sciences Research CouncilWellcome Trust
6 · The paper itself

Abstract

Gremlin1 (Grem1), an antagonist of bone morphogenetic proteins, plays a key role in embryogenesis. A highly specific temporospatial gradient of Grem1 and bone morphogenetic protein signaling is critical to normal lung, kidney, and limb development. Grem1 levels are increased in renal fibrotic conditions, including acute kidney injury, diabetic nephropathy, chronic allograft nephropathy, and immune glomerulonephritis. We demonstrate that a small number of

Indexed as

Acute Kidney InjuryAnimalsCytokinesDisease Models, AnimalFemaleFibrosisFolic AcidGene Expression RegulationGenetic Predisposition to DiseaseIntercellular Signaling Peptides and ProteinsKidney TubulesMice, Inbred C57BLMice, KnockoutOrganogenesisPhenotypeSignal TransductionCytokinesFolic AcidGrem1 protein, mouseIntercellular Signaling Peptides and ProteinsdevelopmentGremlinkidneyrenal fibrosis

Identifiers

PMID28100499
PMCPMC5495891
OpenAlexW2571690050

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.